Clinical Trial Update: Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated stereotactic body radiotherapy (SBRT) given with ipilimumab in patients with metastatic melanoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Radiotherapie | Conditions: Melanoma, Effects of Immunotherapy | Phase 1 | Status: COMPLETED